HCEC-1CT2024-01-02T08:17:40+00:00

Colon

HCEC-1CT

Evercyte ́s human colon epithelial cell line HCEC-1CT can be grown without limitations while maintaining expression of cell type specific markers and functions. Therefore, these cells are useful for setting up in vitro bioassays to study drug / nutrient absorption and to assess drug-induced toxicity on the large intestine barrier. Additionally, the cells are valuable for modelling cancer progression in vitro.

Print Friendly, PDF & Email

from

€ 1600,–

HCEC-1CT
Cat#: CHT-039-0229

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Products

ColoUp medium for growth of HCEC-1CT cells

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about
our cells

interested in testing a drug on HCEC-1CT?

all about
our exosomes

news

Development of tumor targeting EVs

partnership between MDimune and Evercyte / April 2021

Related Products

medium for cultivation of HCEC-1CT cell line

Related Services

testing drugs for a potential cytotoxic activity

Determination of IC50 values of compounds using relevant human telomerized cells

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

HCEC-1CT
Cat#: CHT-039-0229

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Title

Go to Top